If Nutrien sat on your watchlist instead of in your portfolio, the recent performance might feel like a missed call. Investors who held Nutrien over the past year are up 28.9%, including dividends. That move now sits alongside fresh headlines about record potash volumes, cost savings and asset sales. The real question is whether the earlier belief that global food demand and precision agriculture would support fertilizer use was already enough to flag this potential.
If the move has made Nutrien harder to judge, start where the gap is still open and scan 5 high quality undervalued stocks.
The Argument You Would Have Been Weighing Up On Nutrien
The shares cost CA$79.27 at the start of the period, and anyone looking at Nutrien then had to pick between two very different stories about where the fertilizer giant might be heading.
The bullish narrative treated CA$85.56 as a kind of fair value anchor, a price that only made sense if global food demand and precision agriculture kept fertilizer usage resilient. That view leaned on Nutrien using mine automation and cost savings to support higher-margin, premium sales and stronger free cash flow over time.
The bearish script pointed to a Fair Value of CA$62.24, built on concerns that stricter environmental rules and rising carbon costs could squeeze profitability. Under that lens, growing adoption of biological crop inputs and alternative fertilization methods looked like a real threat to long term demand for Nutrien’s traditional products.
What The Results Changed For The Nutrien Thesis
Record potash volumes and higher benchmark prices at Nutrien, along with earlier cost savings and asset sale plans, leaned toward the optimistic case that strong crop nutrient demand and efficiencies could support higher quality cash generation. The measured results told a softer story. Revenue moved from US$10.20b in Q2 2025 to US$10.61b in Q2 2026, while net income was broadly flat and net margin slipped from 12.0% to 11.4%. Overall, the evidence cut both ways.
The episode turned on one assumption. Higher volumes and strong pricing only helped Nutrien when they showed up as stronger margins. When you test another fertilizer stock, track not just sales but also whether net income and net margin move in the same direction as the growth story being sold.
What Nutrien’s Recent Run Now Assumes
Nutrien trades at CA$101 today, after a 28.9% gain over the past year, while the selected Narrative’s Fair Value sits above the current price. That view leans on steady fertilizer demand, cost discipline and capital allocation to support the business.
For a buyer at today’s level, the key judgment is whether Nutrien’s efficiencies and portfolio adjustments can continue to offset fertilizer price swings over time.
"Operational efficiencies, cost reductions, and disciplined capital allocation are enhancing margins, free cash flow, and shareholder returns over the long term. Regulatory pressures, shifting agricultural practices, market dependency, execution risks, and lack of diversification threaten Nutrien's profitability, revenue growth, and future market position."
One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all
Nutrien And The Next Layer
Nutrien highlights how central potash has become to sustaining global crop yields. One step away, another producer is testing a different way to reach this nutrient.
Instead of vast underground workings, this operator uses horizontal drilling along potash seams. The plan focuses on lower upfront spending and faster access to product.
The method also targets a smaller surface footprint, leaving less visible waste. That matters when nearby communities and regulators watch mine impacts closely.
For anyone studying Nutrien, this adds a new angle. How might a lower cost, modular style of Canadian potash production eventually reshape the field?
The case is on the record, with the assumptions it rests on. → See the Narrative that values this company 32% above its price
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com